Ormco Europe’s Post

✨Save the date! 📣OrthoDuo 2 Systems | One result 🎙️Dr. Gabriele Gündel, Dr.* 🎙️Dr. Elizabeth Menzel* 📍 Munich, Germany 📅 April 19-20, 2024 Find out more here: https://hubs.ly/Q02qdNx_0 #Ormco #SparkAligners #orthodontics #clearaligners *Dr. Gabriele Gündel and Dr. Elizabeth Menzel are paid consultants for Ormco. The opinions that are quoted in this material are those of the doctors. Clinicians should use their own judgment in treating their patients. Ormco is a medical device manufacturer and does not provide medical advice.

In the BEAMER project, we are partnering with Universidad Politécnica de Madrid, IDIAPJGol, Innovation Sprint, MYSPHERA, AISM and many other organizations to find an innovative way to improve adherence to treatment in both clinical research and clinical care through optimized and personalized patient support. But we do a lot more than this! Want to know how our Patient Feasibility Services can help you to achieve optimal patient experience and better efficacy and efficiency for your clinical trials? Contact Alexandra Sheren (Americas), Simon Klaasen (Europe &ROW), or Ola Hasselgren (Nordics) to learn more and discuss your specific situation and requirements. Let us know what you think and 𝗳𝗼𝗹𝗹𝗼𝘄 𝘂𝘀. #patientadherence #patientengagement #patientrecruitment #clinicaltrials #clinicaloperations #healthcareinnovations #healthcareprofessionals #patientoutcomes #patientcentricity #clinicalcare #patientexperience #healthjourney #patientjourney #patientparticipation #regulators #valuebasedpricing #valuebasedhealthcare #patientsupport

The patient at the heart: a key value for V|LF-Spiro3D and for Pôle de ressources en Éducation Thérapeutique du Patient (ETP) IDF, another French partner that today we introduce to you. Created in 2013 by field actors and supported by the Regional Health Agency, POLETP’s general mission is to support the development of the ETP in the Ile-de-France region. Its actions are aimed at creating the conditions for its users (#professionals of medico-social structures, #patient associations, #researchers, #institutions, #companies…) to work together to co-construct sustainable solutions accessible to the greatest number of chronically ill people while seeking #equity. In a position of expertise and #mediation, it implements a support system, #training actions, provision of resources, creates a cooperative #network of exchange, and #experience, and provides #knowledge production and solutions created with and for users. Find out the role of POLETP in the project 👉 https://lnkd.in/eyj_CG8h #HorizonEurope #Research #Innovation #VLFSpiro3D

#CTSS #Day1 Dr Sumeet Ambarkhane, MD, Shaantanu Donde, Cornelia Baumgartner- Diolaiuti, Elizabeth Eagling-Vose, MBA, Pauline Frank and Dr. Andriy K. discussed "Optimizing Clinical Development: Leveraging Integrated Medical Affairs and Streamlined Clinical Trial Processes" at #CTSS . . This insightful presentation took place on #Day1 of #CTSS2024! . Keep an eye out for further updates from hashtag #clinicaltrials #16thctss2024 #PharmaInnovation #UnlockPotential #summit2024 #staytunedformore.

We are thrilled to share that Wellster has received official certification from the BSFZ of the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung) as a recognized High-Tech Research & Development company! 🌐✨ This endorsement not only validates the incredible efforts of each team member but also underscores the innovation embedded in the product we're crafting. Our journey is fueled by the desire to address a crucial issue identified by the Ministry - the reluctance among patients to promptly seek treatment for intimate or taboo diseases, often leading to aggravated health issues. The Ministry's acknowledgment reinforces our commitment to making a meaningful impact on healthcare. At the core of our development are several revolutionary, fully digitalized anamnesis, diagnosis, and treatment platforms. 🌟 These platforms offer a comprehensive 360° view of patients, enabling us to often deliver deeper and faster diagnoses compared to traditional doctor visits. This achievement wouldn't have been possible without the dedication and hard work of our incredible team. 🎉 Together, we're not just pushing the boundaries of innovation; we're redefining healthcare standards. 🌈💼 #HighTech #ResearchAndDevelopment #InnovationInHealthcare #CertificationMilestone #ProudTeam #FutureOfHealth

Clarifying AIMIS: More Than a Society or Association Addressing Common Questions: We often get asked, "Is AIMIS a medical society or association?" The answer is a resounding no. AIMIS is a centralized entity with a unique structure. We are a Medical and Surgical Education Society A Network of Excellence: AIMIS is not just an organization; it's a network of surgical "Centers of Excellence" and physician "Practice of Excellence" across the nation. We connect, share information, and collaborate on data collection, technology evaluation, and safety assessments. Beyond Boundaries: Our affiliates go beyond the conventional to foster excellence in healthcare. They work together, driving innovation and setting new standards in the field. Join the AIMIS Difference: AIMIS is where collaboration meets excellence. Explore a dynamic network committed to advancing surgical techniques, ensuring safety, and embracing innovation. Do you have any other questions? DM Christopher Guinn for more information. #AIMIS #HealthcareInnovation #CentersOfExcellence #PhysicianPracticeOfExcellence

For those interested in pain research, please see the attached research articles done by Magstim collaborators! 1. Analgesic effect of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic low back pain. Ambriz‐Tututi, M., Alvarado‐Reynoso, B., & Drucker‐Colín, R. (2016). In this open-label, sham-controlled study, participants with chronic lower back pain were randomized to receive active rTMS (n = 44), sham (n = 12), or physical-therapy (n = 26). In the active group high frequency rTMS (20Hz) at 95% resting motor threshold was delivered to the left M1 for 5 sessions in week 1, followed by 8 further session across the 9 months duration of the study. After 1 week of treatment both the rTMS and physical-therapy groups demonstrated a significant reduction in pain levels, as measured on a visual analogue scale (VAS). However, by week 3 the rTMS group showed an 80% reduction in pain levels, which was significantly greater than the pain reduction achieved in the physical-therapy group. These reductions in VAS scores were maintained across the 9 months of the study for both rTMS and physical-therapy. 2. A 5-day course of rTMS before pain onset ameliorates future pain and increases sensorimotor peak alpha frequency. Nahian S Chowdhury, Khandoker Taseen, Alan Chiang, Wei-Ju Chang, Samantha K Millard, David A Seminowicz, and Siobhan M Schabrun Repetitive transcranial magnetic stimulation (rTMS) has shown promise as an intervention for pain. An unexplored research question is whether the delivery of rTMS prior to pain onset might protect against a future episode of prolonged pain. Compared to sham, individuals who received active rTMS subsequently experienced lower pain on chewing and yawning. Although active rTMS increased PAF, the effects of rTMS on pain were not mediated by changes in PAF or CME. This study is the first to show that rTMS delivered prior to pain onset can protect against future pain and associated functional impairment. Thus, rTMS may hold promise as a prophylactic intervention for persistent pain. Please reach out if you have questions on how Magstim TMS could be used in pain research protocols! #neuroscience #neuromodulation #TMS #Pain

Embracing eConsent: Enhancing Clinical Trials https://buff.ly/3U8muBu #eConsent #clinicaltrials #electronicclinicaltrials

Unmute... Imagine a world where every clinical trial is a seamless fusion of technology and human expertise, where the barriers of language, geography, and socio-economic status are dismantled, ensuring that life-saving treatments reach those in need, swiftly and safely. This is the world that Dr. Harsha K Rajasimha envisions, and it's here with Jeeva Clinical Trials, inc. Don't miss the opportunity to be part of the conversation that's defining the future of medicine. Tune in to Virginia Technology Today and witness the evolution of clinical trials, where diversity, efficiency, and accessibility are not just goals but achievements. Listen now and be inspired by the innovation that's making healthcare history. #clinicaltrials Harsha K Rajasimha, Philippe Sommer, Lara D'Antonio, Virginia Coordinated Clinical Research Network (VCCRN), RAMP - Regional Accelerator and Mentoring Program, #GoVirginia, Carilion Clinic,

👀 Look: These four men share a vision – namely to bring compression therapy to the next level! 💪 Last week, our CPO Dr Klemens Schulz and R&D Director Dr Christian Rohrer met Dr Andrew Cameron (CEO) and Dr. Darren Burke (CTO) of the Irish start-up company FeelTect. FeelTect won the first L&R Accelerator program last autumn. They developed a health device for measuring and monitoring sub bandage pressure during compression therapy, primarily for patients with Venous Lel Ulcers. Dr Klemens Schulz: “Together with FeelTect, we want to shape the future of compression therapy. In the meeting we figured out possible options for a further collaboration between us, e.g. cooperation in clinical studies, healthcare research or trainings.” As a longstanding and highly experienced medical products company, we know all the relevant stages involved in bringing a product to market maturity. Hence, also reimbursement options were discussed among others. # LRMed #compressiontherapy #digitalization #startupcompany #collaboration #futureofhealthcare Picture (from left to right): Andrew Cameron (FeelTect), Klemens Schulz (L&R), Darren Burke (FeelTect) & Christian Rohrer (L&R).